[RESEARCH ] Congratulations to our colleague Thibaut Laboute on his success at the ERDERA 2025 Transnational Call !
ERDERA - MT2ASD project
Dates
from December 18, 2025 to January 18, 2026
MT2ASD – Testing COS01, a novel selective melatonin MT2 receptor agonist, in mouse models of Fragile X syndrome and Phelan-McDermid syndrome.
We are proud to announce that Thibaut Laboute’s project has been selected among the ERDERA 2025 multinational projects, involving INSERM (France) and Canadian partners - More info
Project title:
MT2ASD – Testing COS01, a novel selective melatonin MT2 receptor agonist, in mouse models of Fragile X syndrome and Phelan-McDermid syndrome.
This ambitious project aims to:
Characterise sleep alterations and autism spectrum–like phenotypes
Investigate how COS01 modulates neuronal circuits and molecular pathways
Develop a formulation and regulatory dossier to support future first-in-human studies
The project brings together an excellent international consortium, including:
Gabriella Gobbi, McGill University
Lisa Kelly, Soutien Autisme Soutien
This success highlights the strength of transnational collaboration and the importance of innovative, translational research to advance therapeutic strategies for rare neurodevelopmental disorders.